FAKTOR-OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Real-time Boerse Frankfurt Warrants 06:08:19 2024-06-18 am EDT | ||
| 1.73 EUR | -0.57% |
|
| Current month | -3.33% | ||
| 1 month | +11.54% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-06-18 | 1.73 | -0.57% |
| 24-06-17 | 1.74 | +1.16% |
| 24-06-14 | 1.72 | +2.99% |
| 24-06-13 | 1.67 | +0.60% |
| 24-06-12 | 1.66 | -2.35% |
Real-time Boerse Frankfurt Warrants
Last update June 18, 2024 at 06:08 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SV12L2 |
| ISIN | DE000SV12L22 |
| Date issued | 2023-03-15 |
| Strike | 76.77 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.11 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 21.02 € |
|---|---|
| Lowest since issue | 1.15 € |
| Spread | 0.09 € |
| Spread % | 4.97% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
86.87
USD
Average target price
96.05
USD
Spread / Average Target
+10.57%
- Stock Market
- Certificates
- Certificat
